BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 5164303)

  • 1. A renal lipid inhibitor or erythropoietin.
    Erslev AJ; Kazal LA; Miller OP
    Trans Assoc Am Physicians; 1971; 84():212-6. PubMed ID: 5164303
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of erythropoietin by lipid extracts of kidney and other tissues.
    Kazai LA; Erslev AJ; Miller OP; Abaidoo KJ
    Ann Clin Lab Sci (1971); 1972; 2(3):209-16. PubMed ID: 5082975
    [No Abstract]   [Full Text] [Related]  

  • 3. The action and neutralization of a renal inhibitor of erythropoietin.
    Erslev AJ; Kazal LA; Miller OP
    Proc Soc Exp Biol Med; 1971 Dec; 138(3):1025-9. PubMed ID: 5131602
    [No Abstract]   [Full Text] [Related]  

  • 4. Extrarenal lipid inhibitors of human erythropoietin.
    Abaidoo KJ
    J Am Osteopath Assoc; 1974 Apr; 73(8):664-9. PubMed ID: 4494006
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythropoietin inhibitor in plasma from patients with chronic renal failure.
    Moriyama Y; Saito H; Kinoshita Y
    Haematologia (Budap); 1970; 4(1):15-20. PubMed ID: 5522355
    [No Abstract]   [Full Text] [Related]  

  • 6. [Radioactivity determination of lipid fractions using thin-layer chromatography].
    Nemec R
    Biologia (Bratisl); 1970; 25(9):611-5. PubMed ID: 5506590
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of heparin and hydrocortisone on the activity of kidney erythropoietin inhibitor in experimental renal lesions].
    Popławski A
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1982; 27():247-62. PubMed ID: 6820841
    [No Abstract]   [Full Text] [Related]  

  • 8. Antihypertensive renomedullary lipid in the hypertensive rabbit.
    Muirhead EE; Leach BE; Brooks B; Shaw PH; Brosius WL; Daniels EG; Hinman JW
    Rev Fr Etud Clin Biol; 1967 Nov; 12(9):893-8. PubMed ID: 5591338
    [No Abstract]   [Full Text] [Related]  

  • 9. High-resolution separation and quantification of neutral lipid and phospholipid species in mammalian cells and sera by multi-one-dimensional thin-layer chromatography.
    White T; Bursten S; Federighi D; Lewis RA; Nudelman E
    Anal Biochem; 1998 Apr; 258(1):109-17. PubMed ID: 9527856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lapine renomedullary lipid in murine hypertension.
    Muirhead EE; Leach BE; Daniels ED; Hinman JW
    Arch Pathol; 1968 Jan; 85(1):72-9. PubMed ID: 5634788
    [No Abstract]   [Full Text] [Related]  

  • 11. Occurrence and pharmacologic properties of a lipid substance obtained from rabbit kidney.
    Dyer DC; Walaszek EJ
    J Pharmacol Exp Ther; 1968 Apr; 160(2):360-6. PubMed ID: 5647304
    [No Abstract]   [Full Text] [Related]  

  • 12. Purification of the water-holding lipid of intact skin and burn eschar.
    Jelenko C
    Am Surg; 1969 Dec; 35(12):864-70. PubMed ID: 5355248
    [No Abstract]   [Full Text] [Related]  

  • 13. [The possibility of demonstrating an inhibitor of erythropoiesis in renal vein blood during hyperoxia].
    Voĭtkevich VI; Volzhkaia AM
    Dokl Akad Nauk SSSR; 1970; 191(3):723-5. PubMed ID: 5517323
    [No Abstract]   [Full Text] [Related]  

  • 14. [Research on the renal erythropoietic factor. III. Erythropoietic activity of purified cortical extracts of hog kidney exposed to various temperatures and incubated with homologous plasma].
    Peschle C; Tallarida G; Spina C; Rizzo S; Condorelli M
    Boll Soc Ital Biol Sper; 1967 Dec; 43(24):1788-92. PubMed ID: 5601955
    [No Abstract]   [Full Text] [Related]  

  • 15. [Postmortem changes in organ lipoids].
    Lindlar F
    Z Klin Chem Klin Biochem; 1967 Sep; 5(5):251-3. PubMed ID: 5623864
    [No Abstract]   [Full Text] [Related]  

  • 16. A rapid procedure for elimination of non-polar lipids hampering the usual polar lipid extraction and TLC separation.
    Baldoni E; Bolognani L; Vitaioli L
    Eur J Histochem; 1995; 39(4):253-7. PubMed ID: 8835178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on the effect of heparin and hydrocortisone on the activity of renal erythropoietin inhibitor in experimental kidney damage].
    Popławski A
    Pol Tyg Lek; 1980 Aug; 35(34):1309-10. PubMed ID: 6160565
    [No Abstract]   [Full Text] [Related]  

  • 18. Derivation of antihypertensive neutral renomedullary lipid from renal venous effluent.
    Muirhead EE; Byers LW; Desiderio DM; Pitcock JA; Brooks B; Brown PS; Brosius WL
    J Lab Clin Med; 1982 Jan; 99(1):64-75. PubMed ID: 6798154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for inflammatory and secretagogue lipids in cyst fluids from patients with autosomal dominant polycystic kidney disease.
    Grantham JJ; Schreiner GF; Rome L; Grenz L; Joly A
    Proc Assoc Am Physicians; 1997 Jul; 109(4):397-408. PubMed ID: 9220537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physiologic regulation of erythropoiesis. 3. Inhibition of erythropoietic activity in normal mice and during fasting by means of erythropoietin-neutralizing immune serums].
    Peschle C; Sasso GF; Mastroberardino G; Galante A; Nabavi F; Condorelli M
    G Clin Med; 1968 Dec; 49(12):1275-91. PubMed ID: 5737497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.